JNJ
174.13
+0.25%↑
ABBV
198.84
-0.12%↓
AZN
74.32
+0.36%↑
NVS
118.56
+0.28%↑
ABT
130.85
-2.14%↓
JNJ
174.13
+0.25%↑
ABBV
198.84
-0.12%↓
AZN
74.32
+0.36%↑
NVS
118.56
+0.28%↑
ABT
130.85
-2.14%↓
JNJ
174.13
+0.25%↑
ABBV
198.84
-0.12%↓
AZN
74.32
+0.36%↑
NVS
118.56
+0.28%↑
ABT
130.85
-2.14%↓
JNJ
174.13
+0.25%↑
ABBV
198.84
-0.12%↓
AZN
74.32
+0.36%↑
NVS
118.56
+0.28%↑
ABT
130.85
-2.14%↓
JNJ
174.13
+0.25%↑
ABBV
198.84
-0.12%↓
AZN
74.32
+0.36%↑
NVS
118.56
+0.28%↑
ABT
130.85
-2.14%↓
24 val.
Dabar
Min
1.84
Max
1.93
Rekomendacijos | Pirkti |
---|---|
12 mėnesių prognozė | +281.77% upside |
Kitas uždarbis | 2025-08-18 |
---|
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
2025-03-10 02:12; UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Skaityti
2025-03-10 02:12; UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
2025-03-10 02:06; UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
Kainos pokytis
By TipRanks
12 mėnesių prognozė
Vidutinis 7.33 USD 281.77%
Aukščiausias 16 USD
Žemiausias 2 USD
Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fortress Biotech Inc kainas – Dist per pastaruosius 3 mėnesius.
By TipRanks
Pirkti
3 ratings
2
Pirkti
1
Laikyti
0
Parduoti
Remiantis 3 analitikų, pateikusių Fortress Biotech Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
$